Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$343K Buy
1,588
+54
+4% +$10.3K ﹤0.01% 635
2026
Q1
$281K Buy
1,534
+252
+20% +$46.4K ﹤0.01% 640
2025
Q4
$226K Buy
1,282
+380
+42% +$62.1K ﹤0.01% 603
2025
Q3
$126K Buy
+902
New +$122K ﹤0.01% 724
2025
Q2
Sell
-2,767
Closed -$379K 731
2025
Q1
$379K Buy
2,767
+1,039
+60% +$149K ﹤0.01% 434
2024
Q4
$264K Buy
1,728
+1,428
+476% +$241K ﹤0.01% 492
2024
Q3
$58.2K Sell
300
-923
-75% -$193K ﹤0.01% 852
2024
Q2
$264K Buy
1,223
+181
+17% +$39.3K ﹤0.01% 559
2024
Q1
$270K Sell
1,042
-6
-0.6% -$1.41K ﹤0.01% 461
2023
Q4
$271K Sell
1,048
-115
-10% -$28.2K ﹤0.01% 470
2023
Q3
$299K Sell
1,163
-474
-29% -$127K 0.01% 439
2023
Q2
$466K Buy
+1,637
New +$487K 0.01% 361
2021
Q4
Sell
-721
Closed -$204K 391
2021
Q3
$204K Buy
721
+68
+10% +$22.3K ﹤0.01% 275
2021
Q2
$226K Sell
653
-82
-11% -$24.8K 0.01% 258
2021
Q1
$206K Buy
+735
New +$198K 0.01% 255
2020
Q4
Sell
-963
Closed -$273K 253
2020
Q3
$273K Sell
963
-433
-31% -$121K 0.01% 193
2020
Q2
$373K Buy
+1,396
New +$420K 0.02% 156

Other funds holding BIIB

Mather Group's BIIB Position: Q2 2026 in Review

Mather Group increased its Biogen (BIIB) stake by 3.5% in Q2 2026, buying an estimated $10.3K and bringing the position to 1,588 shares worth $343K. The position accounts for ﹤0.01% of the portfolio, ranked #635.

Mather Group first reported a position in BIIB in Q2 2020 and has held it in 17 quarters since. The position peaked at $466K in Q2 2023. 1,038 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Mather Group held 1,588 shares of Biogen worth $343K as of Q2 2026.
  • Mather Group bought 54 Biogen shares in Q2 2026, an estimated $10.3K.
  • Biogen made up ﹤0.01% of Mather Group's portfolio in Q2 2026, its #635 holding.
  • Mather Group first reported a position in Biogen in Q2 2020 and has held it in 17 quarters since.
  • Mather Group's Biogen position peaked at $466K in Q2 2023.
  • 1,038 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Mather Group's 13F filing for Q2 2026, filed 27 Jul 2026.